Highly pathogenic avian influenza (HPAI) continues to impact commercial poultry facilities in Pennsylvania, prompting state and federal officials to expand response and surveillance efforts.

Updated ACVIM guidance prioritizes therapeutic diets and microbiome-directed therapy, identifying Visbiome Vet as the only probiotic currently backed by randomized clinical trial data for CIE.